Xarelto (Rivaroxaban) Reduces Recurrent Blood Clots and Total Medical Costs in Morbidly Obese Patients - Cath Lab Digest

Xarelto (Rivaroxaban) Reduces Recurrent Blood Clots and Total Medical Costs in Morbidly Obese Patients  Cath Lab Digest

New real-world study of patients with venous thromboembolism (VTE) and morbid obesity shows safety and effectiveness of Xarelto were similar to warfarin, with ...



Comments

Popular posts from this blog

Epidemiology and prevention of venous thromboembolism